HALOZYME THERAPEUTICS, INC. (HALO) has 108 open-market insider trades by 24 insiders since 2006. The most active filer is Randal J. Kirk, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Randal J. Kirk | 10% Owner | — | 20 | $179.3M | 2018-08-28 |
| Helen Torley | CEOPres | — | 20 | $41.9M | 2026-10-08 |
| Michael J. LaBarre | CTOVP | — | 16 | $10.3M | 2025-02-27 |
| Kenneth J. Kelley | Dir | — | 13 | $7.8M | 2021-04-14 |
| Matthew L. Posard | Dir | — | 3 | $5.0M | 2026-10-01 |
| James M. Daly | Dir | — | 3 | $3.7M | 2026-10-01 |
| Connie Matsui | Dir | — | 2 | $3.5M | 2024-11-29 |
| Jeffrey William Henderson | Dir | — | 2 | $2.9M | 2026-05-05 |
| Cortney Caudill | COOVP | — | 2 | $2.5M | 2026-03-10 |
| John Stuart Patton | Dir | — | 3 | $1.6M | 2014-08-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Helen Torley | CEO & President | Sell | $6.6M | 2026-10-06 |
| Matthew L. Posard | Director | Sell | $568K | 2026-10-01 |
| Matthew L. Posard | Director | Sell | $2.0M | 2026-09-16 |
| Helen Torley | CEO & President | Sell | $6.4M | 2026-09-09 |
| Helen Torley | CEO & President | Sell | $6.3M | 2026-08-17 |
| Bernadette Connaughton | Director | Sell | $167K |
Companies that share insiders with HALO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-08-10 |
| Helen Torley | CEO & President | Sell | $153K | 2026-07-08 |
| Bernadette Connaughton | Director | Sell | $125K | 2026-07-01 |
| Mahesh Krishnan | Director | Sell | $548K | 2026-06-29 |
| Helen Torley | CEO & President | Sell | $3.4M | 2026-06-01 |
| Bernadette Connaughton | Director | Sell | $108K | 2026-06-01 |
| Helen Torley | CEO & President | Sell | $3.4M | 2026-05-11 |
| Bernadette Connaughton | Director | Sell | $103K | 2026-05-01 |
| Helen Torley | CEO & President | Sell | $635K | 2026-04-06 |
| Helen Torley | CEO & President | Sell | $2.6M | 2026-04-01 |